Rossing P, Baeres FMM, Bakris G et al (2023) The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease
Safety: GI side effects were more common (70.8% with 7.2 mg vs 61.2% with 2.4 mg), but serious adverse events were comparable across groups
Weightly Allows users to log injections, weight changes, and side effects, and visualize progress with clear graphs and reminders
However, a patient may need several dosages to correct a deficiency
Aqu hay algunas cosas que los consumidores pueden querer tener en cuenta: 1
Read more: To view or add a comment, sign in AL Amyloidosis is a rare disease in which abnormal light chains proteins accumulate in vital organs, including the heart and kidneys, affecting their function